Last update 10 Jun 2025
Iview Therapeutics Zhuhai) Co., Ltd.

Iview Therapeutics Zhuhai) Co., Ltd.

Subsidiary Company|2019|Guangdong Sheng, China|
www.iview-cn.com

Overview

Basic Info

Introduction
Aiwei Pharmaceutical Zhuhai Co., Ltd. is a business entity based in China that specializes in the production of biopharmaceutical goods.

Tags

Eye Diseases
Other Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug4
Top 5 TargetCount
TRPM8(Transient receptor potential cation channel subfamily M member 8)1
mAChRs(Muscarinic acetylcholine receptor)1

Related

4
Drugs associated with Iview Therapeutics Zhuhai) Co., Ltd.
IVIEW-1001
Target
TRPM8
Mechanism
TRPM8 agonists
Active Org.
iVIEW Therapeutics, Inc.iVIEW Therapeutics, Inc.
 [+1]
Originator Org.
iVIEW Therapeutics, Inc.iVIEW Therapeutics, Inc.
Active Indication
Xerophthalmia
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date-
IVIEW-1802
Target
mAChRs
Mechanism
mAChRs antagonists
Active Org.
iVIEW Therapeutics, Inc.iVIEW Therapeutics, Inc.
 [+1]
Originator Org.
iVIEW Therapeutics, Inc.iVIEW Therapeutics, Inc.
Active Indication
Myopia
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
IVIEW-1701
Target-
Mechanism-
Active Org.
Iview Therapeutics Zhuhai) Co., Ltd.Iview Therapeutics Zhuhai) Co., Ltd.
Originator Org.
iVIEW Therapeutics, Inc.iVIEW Therapeutics, Inc.
Active Indication
Post procedural inflammation [+1]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Iview Therapeutics Zhuhai) Co., Ltd.
CTR20202563
/ TerminatedPhase 2
一项评估IVIEW-1201治疗急性腺病毒性结膜炎疗效的双盲、安慰剂对照、随机、Ⅱ期临床试验
[Translation] A double-blind, placebo-controlled, randomized, phase II clinical trial to evaluate the efficacy of IVIEW-1201 in the treatment of acute adenoviral conjunctivitis
100 Clinical Results associated with Iview Therapeutics Zhuhai) Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Iview Therapeutics Zhuhai) Co., Ltd.
Login to view more data
100 Deals associated with Iview Therapeutics Zhuhai) Co., Ltd.
Login to view more data
100 Translational Medicine associated with Iview Therapeutics Zhuhai) Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 17 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
3
1
IND Application
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
IVIEW-1701
Uveitis, Anterior
More
Preclinical
IVIEW-3001
Corneal Neovascularization
More
Preclinical
IVIEW-1802
 ( mAChRs )		Myopia
More
Preclinical
IVIEW-1902
Presbyopia
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free